News
TOI
2.450
-6.49%
-0.170
Weekly Report: what happened at TOI last week (0202-0206)?
Weekly Report · 3d ago
Weekly Report: what happened at TOI last week (0126-0130)?
Weekly Report · 02/02 10:22
Weekly Report: what happened at TOI last week (0119-0123)?
Weekly Report · 01/26 10:22
Weekly Report: what happened at TOI last week (0112-0116)?
Weekly Report · 01/19 10:28
Buying the Dip on TOI: Strong 2026 Outlook, Underappreciated Profitability, and Valuation Upside
TipRanks · 01/13 12:25
The Oncology Institute Inc. Files Initial Statement of Beneficial Ownership for Director Mark Stolper
Reuters · 01/12 21:57
The Oncology Institute reaffirms 2025 guidance, projects 2026 revenue
Seeking Alpha · 01/12 13:36
Oncology Institute sees FY26 revenue $630M-$650M
TipRanks · 01/12 13:11
Oncology Institute seeks to grow revenue at annual rate of 20% through 2028
TipRanks · 01/12 13:11
The Oncology Institute Projects 2026 Revenue to Hit $650M
Benzinga · 01/12 13:07
*Oncology Institute Believes Margins Have Potential to Expand Through 2028 to Mid-Single-Digit Range as a Percentage of Rev >TOI
Dow Jones · 01/12 13:06
*Oncology Institute Seeks to Grow Rev at Annual Rate of About 20% Through 2028 >TOI
Dow Jones · 01/12 13:06
*Oncology Institute Believes Capitation, Dispensary Rev Could Rise to About 30%, 50% of Total Rev, Respectively >TOI
Dow Jones · 01/12 13:06
*Oncology Institute Sees 2026 Rev $630M-$650M >TOI
Dow Jones · 01/12 13:05
The Oncology Institute Targets 20% Annual Revenue Growth Through 2028
Reuters · 01/12 13:00
ONCOLOGY INSTITUTE INC - ANTICIPATES 2026 REVENUE BETWEEN $630 MLN AND $650 MLN
Reuters · 01/12 13:00
ONCOLOGY INSTITUTE INC: LOOKING BEYOND 2026, CO IS WELL POSITIONED FOR CONTINUED EXPANSION
Reuters · 01/12 13:00
Press Release: The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook
Dow Jones · 01/12 13:00
Weekly Report: what happened at TOI last week (0105-0109)?
Weekly Report · 01/12 10:27
More
Webull provides a variety of real-time TOI stock news. You can receive the latest news about The Oncology Institute Inc through multiple platforms. This information may help you make smarter investment decisions.
About TOI
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.